The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and Type 1 retinopathy of prematurity

被引：0
|
作者：
Ayşegül Çömez
Yalçın Karaküçük
Mehmet Cüneyt Özmen
Pelin Çelemler
Oğuzhan Saygılı
机构：
[1] Sutcu Imam University,Department of Ophthalmology, Faculty of Medicine
[2] Selcuk University,Department of Ophthalmology, Faculty of Medicine
[3] Gazi University School of Medicine,Department of Ophthalmology
[4] Gaziantep Children’s Hospital,Department of Ophthalmology
[5] Gaziantep University,Department of Ophthalmology, Faculty of Medicine
来源：
Eye | 2021年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3302 / 3310
页数：8
相关论文
共 50 条
  • [31] Evaluation of monotherapy of intravitreal Bevacizumab in retinopathy of prematurity stage 3 plus
    Shirzadeh, S.
    [J]. ACTA OPHTHALMOLOGICA, 2016, 94
  • [32] Clinical Management of Recurrent Retinopathy of Prematurity after Intravitreal Bevacizumab Monotherapy
    Mintz-Hittner, Helen A.
    Geloneck, Megan M.
    Chuang, Alice Z.
    [J]. OPHTHALMOLOGY, 2016, 123 (09) : 1845 - 1855
  • [33] Very Late Reactivation of Retinopathy of Prematurity After Monotherapy With Intravitreal Bevacizumab
    Snyder, Laura L.
    Garcia-Gonzalez, Jose Maria
    Shapiro, Michael J.
    Blair, Michael P.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2016, 47 (03): : 280 - 283
  • [34] Intravitreal bevacizumab monotherapy for type-1 prethreshold, threshold, and aggressive posterior retinopathy of prematurity-27 month follow-up results from Turkey
    Yetik, Huseyin
    Gunay, Murat
    Sirop, Sarkis
    Salihoglu, Ziya
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 253 (10) : 1677 - 1683
  • [35] Type 1 retinopathy of prematurity: time to regressionfollowing treatment with intravitreal bevacizumab
    Tehrani, Nasrin Najm
    Isaac, Maram
    Mireskandari, Kamiar
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [36] Aggressive Posterior Retinopathy of Prematurity Treated with Intravitreal Bevacizumab: Late Period Fluorescein Angiographic Findings
    Irfan Perente
    Erdem Eris
    Zeynep Seymen
    S. Gorkem Cevik
    Sinan Bekmez
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 1141 - 1146
  • [37] Aggressive Posterior Retinopathy of Prematurity Treated with Intravitreal Bevacizumab: Late Period Fluorescein Angiographic Findings
    Perente, Irfan
    Eris, Erdem
    Seymen, Zeynep
    Cevik, S. Gorkem
    Bekmez, Sinan
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (06) : 1141 - 1146
  • [38] Comparison of intravitreal bevacizumab monotherapy and combined laser photocoagulation and intravitreal bevacizumab therapy in the same session in the treatment of aggressive retinopathy of prematurity
    Sabanci, Senol
    Kucuk, Mehmet Fatih
    Suren, Elcin
    Erol, Muhammet Kazim
    [J]. INTERNATIONAL OPHTHALMOLOGY, 2024, 44 (01)
  • [39] Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity
    Quiroz-Mercado, Hugo
    Martinez-Castellanos, Maria A.
    Hernandez-Rojas, Myriam L.
    Salazar-Teran, Nelida
    Chan, Robinson Vernon Paul
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (03): : S19 - S25
  • [40] Intravitreal Bevacizumab for Zone II Retinopathy of Prematurity
    Larranaga-Fragoso, Paula
    Peralta, Jesus
    Bravo-Ljubetic, Luciano
    Pastora, Natalia
    Abelairas-Gomez, Jose
    [J]. JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, 2016, 53 (06) : 375 - 382
12345